CGT image

Preclinical Cell and Gene Therapy Research

For cell and gene therapy programs requiring controlled in vivo studies, the contract vivarium model provides a stable research environment with integrated operational support.

Choose a Location

Enabling Innovation in Cell and Gene Therapy Research

Built for the complex demands of cell and gene therapy development, Mispro provides controlled, compliant contract vivarium environments with integrated husbandry, veterinary care, and regulatory oversight services. Scientists maintain direct control of study design and execution while generating reproducible in vivo data that informs early development decisions in genome editing, viral vector delivery, and advanced therapeutic platforms.

Across our network of AAALAC-accredited contract vivarium facilities, biotech teams can conduct non-GLP rodent studies supporting target validation, vector performance, gene editing outcomes, and therapeutic response.

Mispro’s research environments support a wide range of cell and gene therapy study designs, including:

  • Viral vector and gene delivery evaluation
  • Genome editing and gene expression studies
  • Cell-based therapy efficacy and persistence studies
  • Longitudinal assessment of therapeutic response
stock whiteboarding

Contract Vivarium Lab Space for CGT Research

Emerging and established biotech and biopharma teams advancing cell therapies, gene therapies, and genome editing technologies benefit from controlled in vivo research environments that support complex experimental designs and parallel study workflows. Mispro’s contract vivarium model provides research-ready vivarium space with integrated animal care and regulatory support, allowing scientists to maintain direct oversight of CGT studies within a professionally managed setting.

Vivarium infrastructure and operational support designed to replace build and outsource models:

  • Private holding and procedure room options, including dedicated private suites suitable for complex study setups
  • Rooms outfitted with essential equipment for safe and stable animal studies, including IVC racks and caging systems and biosafety cabinets
  • Procedure rooms with sufficient space for specialized equipment and parallel experimental workflows
  • 365-day animal husbandry, health monitoring, and veterinary oversight ensuring consistent observation and care for animals enrolled in CGT studies

Whether your company is pioneering a new drug, is on the forefront of cell and gene therapy, or has a team of scientists pursuing platform targets, Mispro is an optimal environment for your in vivo drug development research.

Cell and Gene Therapy Research Areas Supported

Mispro’s contract vivarium environments support preclinical in vivo research across a wide range of cell and gene therapy development programs, including:

  • Viral vector–based gene therapy research
  • Genome editing technologies such as CRISPR and base editing
  • Cell-based therapies including engineered immune cell therapies
  • Genetic disease and rare disease therapeutic development

Innovation Across Our Network

  • 88% Novel / Proprietary Research
  • 58% Translational Programs
  • 46% Platform Companies

Mispro vs. CRO

  • 6X Increase in study throughput
  • 50% Less spend over time
  • 70% Reduction in failure rates

Where Cutting-Edge Therapies Meet Expert Animal Care

We provide the controlled environments and expert oversight your cell and gene therapy models require.